| |
| |
|
| Insider
Information: |
Kutzkey Tim |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
35,728,642 |
|
|
Indirect Shares
|
4,162,673 |
|
|
| Direct
Value |
$434,916,061 |
|
|
|
Indirect Value
|
$124,372,793 |
|
|
| Total
Shares |
39,891,315 |
|
|
| Total
Value |
$559,288,854 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
10
|
1
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
2
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
-1.0
|
| Percentage
Gain/Loss : |
 42.8%
|
 -8.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcus Biosciences Inc |
RCUS |
10% Owner |
2018-03-19 |
470,427 |
2018-03-19 |
0 |
Premium* |
|
|
Immune Design Corp. |
IMDZ |
10% Owner |
2017-10-27 |
6,642,942 |
2017-10-27 |
0 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2021-02-17 |
2,584,957 |
2021-02-17 |
3,645,681 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
Managing Partner, 10% ... |
2020-09-02 |
18,052,932 |
2020-09-02 |
190,000 |
Premium* |
|
|
Revolution Medicines, Inc. |
RVMD |
Managing Partner, 10% ... |
2020-02-18 |
7,977,384 |
2020-02-18 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
|
|
0 |
2024-04-04 |
326,992 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRZN |
Surrozen Ord Shs |
|
– • • |
2024-04-04 |
4/A |
B |
$15.50 |
$2,999,994 |
I/I |
193,548 |
326,992 |
0.01 |
- |
|
| SRZN |
Surrozen Ord Shs |
|
– • • |
2024-04-04 |
4 |
B |
$15.50 |
$2,999,994 |
I/I |
193,548 |
332,885 |
0.01 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2017-10-27 |
4 |
B |
$4.10 |
$10,992,100 |
D/D |
2,681,000 |
6,642,942 |
2.45 |
- |
|
| RCUS |
Arcus Biosciences Inc |
10% Owner |
– – • |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,540,850 |
470,427 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
10% Owner |
– – • |
2018-07-23 |
4 |
A |
$0.00 |
$0 |
I/I |
79,155 |
79,155 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
10% Owner |
– – • |
2018-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,666,888 |
4,677,939 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2019-04-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,890,000 |
|
- |
|
| CNST |
Constellation Pharmaceuti... |
10% Owner |
– – • |
2020-12-14 |
4 |
OE |
$1.55 |
$46,666 |
D/D |
30,107 |
2,584,957 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
10% Owner |
– – • |
2021-02-17 |
4 |
S |
$36.95 |
$369,503 |
I/I |
(10,000) |
99,155 |
0 |
% |
|
| SRZN |
Surrozen Ord Shs |
Director |
– • • |
2021-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,248,129 |
|
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
General Partner |
– – • |
2019-06-12 |
4 |
B |
$14.00 |
$104,989 |
D/D |
7,500 |
2,056,123 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
General Partner |
– – • |
2019-06-13 |
4 |
B |
$14.13 |
$162,508 |
D/D |
11,500 |
2,067,623 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
General Partner |
– – • |
2019-06-14 |
4 |
B |
$14.00 |
$150,687 |
D/D |
10,760 |
2,078,383 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-04-08 |
4 |
B |
$16.00 |
$30,240,000 |
D/D |
1,890,000 |
15,000 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
13,093,134 |
13,569,091 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-05-07 |
4 |
B |
$14.10 |
$803,700 |
D/D |
57,000 |
1,932,000 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-05-10 |
4 |
B |
$13.85 |
$248,234 |
D/D |
17,923 |
1,949,923 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-05-20 |
4 |
B |
$13.50 |
$675,000 |
D/D |
50,000 |
1,999,923 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-04 |
4 |
B |
$13.39 |
$168,764 |
D/D |
12,600 |
2,012,523 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-06 |
4 |
B |
$13.40 |
$168,884 |
D/D |
12,600 |
2,025,123 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-07 |
4 |
B |
$13.66 |
$172,176 |
D/D |
12,600 |
2,037,723 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-11 |
4 |
B |
$13.83 |
$150,718 |
D/D |
10,900 |
2,048,623 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-19 |
4 |
B |
$13.91 |
$211,674 |
D/D |
15,214 |
2,093,597 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-20 |
4 |
B |
$13.86 |
$213,385 |
D/D |
15,400 |
2,108,997 |
2.45 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
– – • |
2019-06-21 |
4 |
B |
$14.03 |
$52,789 |
D/D |
3,763 |
2,112,760 |
2.45 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
